Cas:886496-49-7 4-Fluoro-3-(trifluoromethoxy)benzoic acid manufacturer & supplier

We serve Chemical Name:4-Fluoro-3-(trifluoromethoxy)benzoic acid CAS:886496-49-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Fluoro-3-(trifluoromethoxy)benzoic acid

Chemical Name:4-Fluoro-3-(trifluoromethoxy)benzoic acid
CAS.NO:886496-49-7
Synonyms:4-fluoro-3-(trifluoromethoxy)benzoic acid
Molecular Formula:C8H4F4O3
Molecular Weight:224.10900
HS Code:2918990090

Physical and Chemical Properties:
Melting point:86-90ºC
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.53000
Exact Mass:224.01000
LogP:2.42250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-fluoro-3-(trifluoromethoxy)benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-fluoro-3-(trifluoromethoxy)benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-fluoro-3-(trifluoromethoxy)benzoic acid Use and application,4-fluoro-3-(trifluoromethoxy)benzoic acid technical grade,usp/ep/jp grade.


Related News: This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 4-Fluoro-3-(trifluoromethoxy)benzoic acid manufacturer Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 4-Fluoro-3-(trifluoromethoxy)benzoic acid supplier But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said. 4-Fluoro-3-(trifluoromethoxy)benzoic acid vendor This also includes its anti-tau pipeline, with the FDA’s approval having “implications for AD programmes targeting Tau,” according to Jefferies. 4-Fluoro-3-(trifluoromethoxy)benzoic acid factory The FDA approval allows Biogen to sell its product over several years – with forecasts for potential annual sales reaching as high $10 billion to $50 billion – until the company completes a required follow-up study.